Oakley Bowden Pharma Private Limited - Company Profile

It is a real estate private limited company based in Egmore, Chennai 8, Tamil Nadu, India, established in 1993.
1993 Egmore, Chennai 8, Tamil Nadu, India Amalgamated
Last Updated:
Access Report
About Oakley Bowden Pharma Private Limited

Oakley Bowden Pharma Private Limited, a amalgamated private limited company, was established on 07 May 1993 in Egmore, Chennai 8, Tamil Nadu, India. Engaging in real estate leasing within the real estate sector, it holds CIN: U24231TN1993PTC025025. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹1.63 M.

It upholds a compliant status. Its leadership includes Kishor Lal Daga (Director), Thiyagarajan (Additional Director). Past directors included Siddhartha Daga, Suresh Kumar Sewag. It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at Unit N O 9B 3Rd Floorr A Building No 72, Marshalls Road, Egmore, Chennai 8, Tamil Nadu, 600008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN1993PTC025025

  • Registration Number

    025025

  • Incorporation Date

    07 May 1993

  • Authorized Capital

    ₹4.50 M

  • Paid-Up Capital

    ₹1.63 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 4.50 M
  • Paid Up Capital ₹ 1.63 M
  • Company Age 32 Year, 10 Months
  • Last Filing with ROC 31 Mar 2020
  • Satisfied Charges ₹ 5.00 M
Company report

Oakley Bowden Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Oakley Bowden Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oakley Bowden Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kishor Lal Daga Director 01 Nov 2009 Current
Thiyagarajan Additional Director 22 Jan 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2009 Past
Pramod Abcsdd Director 22 Jan 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oakley Bowden Pharma.

Oakley Bowden Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Oakley Bowden Pharma revenue growth over time
Oakley Bowden Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oakley Bowden Pharma?

In 2017, Oakley Bowden Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹5,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
07 Jan 2004 State Bank Of India ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Oakley Bowden Pharma?

Unlock and access historical data on people associated with Oakley Bowden Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oakley Bowden Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oakley Bowden Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oakley Bowden Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Thiyagarajan was appointed as a Additional Director was appointed as a Additional Director on 22 Jan 2021 & has been associated with this company since 5 years 1 month . was documented.

  • Annual General Meeting

    Oakley Bowden Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Oakley Bowden Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Chennai. was documented.

  • Charges

    A charge registered on 07 Jan 2004 via Charge ID 90281593 with State Bank Of India was fully satisfied on 02 Aug 2017. was recorded as a recent event.

  • Director Appointment

    Progress on Kishor Lal Daga was appointed as a Director was appointed as a Director on 01 Nov 2009 & has been associated with this company since 16 years 4 months . was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 5.00 M with Charge ID 90281593 was registered on 07 Jan 2004. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Oakley Bowden Pharma Private Limited?

The CIN of Oakley Bowden Pharma Private Limited is U24231TN1993PTC025025.

Where is Oakley Bowden Pharma Private Limited headquartered?

Oakley Bowden Pharma Private Limited is headquartered at Unit N O 9B 3Rd Floorr A Building No 72, Marshalls Road, Egmore, Chennai 8, Tamil Nadu, 600008.

When was Oakley Bowden Pharma Private Limited incorporated?

Oakley Bowden Pharma Private Limited was incorporated on 07 May 1993.

Who are the current directors of Oakley Bowden Pharma Private Limited?

The current directors of Oakley Bowden Pharma Private Limited are

What is the primary industry of Oakley Bowden Pharma Private Limited?

The primary industry of Oakley Bowden Pharma Private Limited is Real Estate.

Is Oakley Bowden Pharma Private Limited a listed company?

Oakley Bowden Pharma Private Limited is unlisted.

What is the capital structure of Oakley Bowden Pharma Private Limited?

The authorized capital of Oakley Bowden Pharma Private Limited is ₹4.50 M, and the paid-up capital is ₹1.63 M.

What is the compliance status of Oakley Bowden Pharma Private Limited?

The compliance status of Oakley Bowden Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available